Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZMIZ1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
mRNA | GPR89A | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
mRNA | CASP2 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | RUNX1T1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | AP3M2 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | ZNF417 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | ZCCHC18 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
mRNA | KCNRG | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
mRNA | STMN1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
mRNA | ZFP30 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |